Morningstar Investment Management LLC Has $2.39 Million Stock Position in Agilent Technologies, Inc. $A

Morningstar Investment Management LLC lifted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 27.1% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 20,965 shares of the medical research company’s stock after purchasing an additional 4,475 shares during the period. Morningstar Investment Management LLC’s holdings in Agilent Technologies were worth $2,390,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA grew its position in shares of Agilent Technologies by 13.8% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after acquiring an additional 1,713,216 shares during the period. State Street Corp raised its stake in Agilent Technologies by 1.9% in the fourth quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock valued at $1,725,611,000 after buying an additional 241,029 shares during the period. Geode Capital Management LLC lifted its position in shares of Agilent Technologies by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after buying an additional 25,139 shares during the last quarter. Morgan Stanley boosted its stake in shares of Agilent Technologies by 15.9% during the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock worth $686,049,000 after acquiring an additional 692,202 shares during the period. Finally, Norges Bank acquired a new position in shares of Agilent Technologies during the 4th quarter worth approximately $549,158,000.

Agilent Technologies Stock Down 0.8%

A opened at $138.65 on Friday. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The company has a market capitalization of $39.16 billion, a P/E ratio of 27.84, a P/E/G ratio of 2.46 and a beta of 1.25. The stock has a fifty day moving average of $129.75 and a 200-day moving average of $125.55.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the prior year, the company posted $1.31 earnings per share. Agilent Technologies’s revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities analysts expect that Agilent Technologies, Inc. will post 6.01 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were given a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is presently 20.48%.

Wall Street Analyst Weigh In

A has been the subject of several research reports. Sanford C. Bernstein assumed coverage on Agilent Technologies in a report on Friday, June 26th. They set an “outperform” rating and a $155.00 price target for the company. TD Cowen raised their target price on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Wells Fargo & Company decreased their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, May 28th. Jefferies Financial Group began coverage on shares of Agilent Technologies in a report on Thursday, July 9th. They issued a “hold” rating and a $135.00 price target on the stock. Finally, Piper Sandler began coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective for the company. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $159.35.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.